Clinical manifestations, natural history, and differential diagnosis of reflux esophagitis

Gastroesophageal Reflux Disease

Volumn , Issue , 2016, Pages 1-25

  McNally, Peter R ^a  

^a EISENHOWER ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2942730100     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (114)

1. Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 1976; 21:953-956.
2. Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptomatic gastro-oesophageal disease. Lancet 1990; 335:205-208.
3. Price SF, Smithson KW, Castell DO. Food sensitivity in reflux esophagitis. Gastroenterology 1978; 75:240-243.
4. Iwakiri K, Kobayashi M, Kotoyori M, Yamada H, Sugiura T, Nakagawa Y. Relationship between postprandial esophageal acid exposure and meal volume and fat content. Dig Dis Sci 1996; 41:926-930.
5. Borum ML. Gastrointestinal diseases in women. Med Clin North Am 1998; 82: 21-50.
6. Homan CS, Maitra SR, Lane BP, Thode HC, Finkelsteyn J, Davidson C. Histopathologic evaluation of the therapeutic efficacy of milk and water dilution for acid injury. Acad Emerg Med 1995; 2:952-958.
7. Berstad A, Hatlebakk JJ. The predictive value of symptoms in gastro-oesophageal reflux disease. Scand J Gastroenterol 1995; 211:1-4.
8. Rodriguez S, Miner P, Robinson M, Greenwood B, Maton PN, Pappa K. Meal type affects heartburn severity. Dig Dis Sci 1998; 43:485-490.
9. Grande L, Manterola C, Ros E, Lacima G, Pera C. Effects of red wine on 24-hour esophageal pH and pressures in healthy volunteers. Dig Dis Sci 1997; 42:1189-1193.
10. Feldman M, Barnett C. Relationship between the acidity and osmolarity of popular beverages and reported postprandial heartburn. Gastroenterology 1995; 108:125-131.
11. Brazer SR, Onken JE, Dalton CB, Smith JW, Schiffman SS. Effects of different coffees on esophageal acid contact time and symptoms in coffee-sensitive subjects. Physiol Behav 1995; 57:563-567.
12. Pehl C, Wendl B, Pfeiffer A, Schmidt J, Kaess H. Low-proof alcoholic beverages and gastroesophageal reflux. Dig Dis Sci 1993; 38:93-96.
13. Katz LC, Just R, Castell DO. Body position affects recumbent postprandial reflux. J Clin Gastroenterol 1994; 18:280-283.
14. Moses FM. The effect of exercise on the gastrointestinal tract. Sports Med 1990; 9:159-172.
15. Sjogren RW. Gastrointestinal features of scleroderma. Curr Opin Rheumatol 1996; 8:569-575.
16. Bassotti G, Battaglia E, Debernardi V, Germani U, Quiriconi F, Dughera L, Buonafede G, Puiatti P, Morelli A, Spinozzi, Mioli PR, Emanuelli G. Esophageal dysfunction in scleroderma: relationship with disease subsets. Arthritis Rheum 1997; 40:2252-2259.
17. Weston S, Thumshirn M, Wiste J, Camilleri M. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol 1998; 93:1085-1089.
18. Medgser TA, Masi AT. Epidemiology of systemic sclerosis (scleroderma). Ann Intern Med 1971; 74:714-721.
19. Poirier TJ, Rankin GB. Gastrointestinal manifestations of progressive system scleroderma based on a review of 364 cases. Am J Gastroenterol 1972; 58:30-44.
20. Recht MP, Levine MS, Katzka DA, Reynolds JC, Saul SH. Barrett's esophagus in scleroderma: increased prevalence and radiographic findings. Gastrointest Radiol 1988; 13:1-5.
21. Zamost BJ, Hirschberg J, Ippoliti AF, Furst DE, Clements PJ, Weinstein WM. Esophagitis in scleroderma: prevalence and risk factors. Gastroenterology 1987; 92:421-428.
22. Katzka DA, Reynolds JC, Saul SM, Plotkin A, Lang CA, Ouyang A, Jimenez S, Cohen S. Barrett's metaplasia and adenocarcinoma of the esophagus in scleroderma. Am J Med 1987; 82:46-52.
23. Anselmino M, Zaninotto G, Constantini M, Ostuni P, Ianniello A, Boccu C, Doria A, Todesco S, Ancona E. Esophageal motor function in primary Sjögren's syndrome: correlation with dysphagia and xerostomia. Dig Dis Sci 1997; 42:113-118.
24. Camilleri M. Gastrointestinal problems in diabetes. Endocrinol Metab Clin North Am 1996; 25:361-378.
25. Faigel DO, Metz DC. Prevalence, etiology, and prognostic significance of upper gastrointestinal hemorrhage in diabetic ketoacidosis. Dig Dis Sci 1996; 41:1-8.
26. Katz PO, Castell DO. Gastroesophageal reflux disease during pregnancy. Gastroenterol Clin North Am 1998; 27:153-167.
27. Bainbridge ET, Temple JG, Nicholas SP, Newton JR, Boriah V. Symptomatic gastro-oesophageal reflux in pregnancy. A comparative study of white Europeans and Asians in Birmingham. Br J Clin Pract 1983; 37:53-57.
28. Bassey OO. Pregnancy heartburn in Nigerians and Caucasians with theories about etiology based on manometric recordings for the oesophagus and stomach. Br J Obstet Gynaecol 1977; 84:439-443.
29. Nagler R, Spiro HM. Heartburn in pregnancy. Am J Dig Dis 1962; 7:648-655.
30. Larson JD, Patatanian E, Miner PB, Rayburn WF, Robinson MG. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy. Obstet Gynecol 1997; 90:83-87.
31. Miller LS, Vinayek R, Frucht H, Gardner JD, Jensen RT, Maton PN. Reflux esophagitis in patients with Zollinger-Ellison syndrome. Gastroenterology 1990; 98:341-346.
32. Bondeson AG, Bondeson L, Thompson NW. Stricture and perforation of the esophagus: overlooked threats in Zollinger-Ellison syndrome. World J Surg 1990; 14: 361-363.
33. Miyoshi H, Yata M, Matsuo N, Sameshima Y, Harima T. Nasogastric tube feeding and esophageal disorders. Intern Med 1998; 37:102.
34. Buchman AL, Waring JP. Mucosal bridge formation in the esophagus caused by injury from a nasoenteric feeding tube. J Parenteral Enteral Nutr 1994; 18:278-279.
35. Helm JF, Dodds WJ, Hogan WJ. Salivary response to esophageal acid in normal subjects and patients with reflux esophagitis. Gastroenterology 1987; 93:1393-1397.
36. Helm JF, Dodds WJ, Pelc LR, Palmer DW, Hogan WJ, Teeter BC. Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med 1984; 310:284-288.
37. Korsten MA, Rosman AS, Fishbein S, Shlein RD, Goldberg HE, Bieher A. Chronic xerostomia increases esophageal acid exposure and is associated with esophageal injury. Am J Med 1991; 90:701-706.
38. Sheikh SH, Shaw-Stiffel TA. The gastrointestinal manifestations of Sjögren's syndrome. Am J Gastroenterol 1995; 90:9-14.
39. Axelrad AM, Fleischer DC. Esophageal tumors. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 6th ed. Philadelphia: WB Saunders, 1998:540-554.
40. Parkman HP, Cohen S. Heartburn, regurgitation, odynophagia, chest pain and dysphagia. In: Haubrich WS, Schaffner F, Berk JE, eds. Bockus Gastroenterology, 5th ed. Philadelphia: WB Saunders, 1995:30-40.
41. Brown CM, Snowdon CF, Slee B, Sandle LN, Rees WD. Effects of topical oesophageal acidification on human salivary and esophageal alkali secretion. Gut 1995; 36: 649-653.
42. Mandel L, Tamari K. Sialorrhea and gastroesophageal reflux. J Am Dent Assoc 1995; 126:1537-1541.
43. Brown CM, Rees WD. Review article: factors protecting the oesophagus against acid-mediated injury. Aliment Pharmacol Ther 1995; 9:251-262.
44. Goldin GF, Marcinkiewicz M, Zbroch T, Bityutskiy LP, McCallum RW, Sarosiek J. Esophagoprotective potential of cisapride. An additional benefit for gastroesophageal reflux. Dig Dis Sci 1997; 42:1362-1369.
45. Decktor DL, Allen ML, Robinson M. Esophageal motility, heartburn, and gastroesophageal reflux: variations in clinical presentation of esophageal dysphagia. Dysphagia 1990; 5:211-215.
46. Singh S, Stein HJ, DeMeester TR, Hinder RA. Nonobstructive dysphagia in gastroesophageal reflux disease: a study with combined ambulatory pH and motility monitoring. Am J Gastroenterol 1992; 87:562-567.
47. Jacob P, Kahrilas PJ, Vanagunas A. Peristaltic dysfunction associated with nonobstructive dysphagia in reflux disease. Dig Dis Sci 1990; 35:939-942.
48. Geisinger KR. Endoscopic biopsies and cytological brushings of the esophagus are diagnostically complementary. Am J Clin Pathol 1995; 103:295-299.
49. Alexander LN, Wilcox CM. A prospective trial of thalidomide for the treatment of HIV-associated idiopathic esophageal ulcers. AIDS Res Hum Retroviruses 1997; 13:301-304.
50. Clayton F, Clayton CH. Gastrointestinal pathology in HIV-infected patients. Gastroenterol Clin North Am 1997; 26:191-240.
51. Maillot C, Riachi G, Francois A, Ducrotte P, Lerebours E, Hemet J, Colin R. Digestive manifestations in an immunocompetent adult with varicella. Am J Gastroenterol 1997; 92:1361-1363.
52. Choi JH, Yoo JH, Chung IJ, Kim DW, Han CW, Shin WS, Min WS, Park CW, Kim CC, Kim DJ. Esophageal aspergillosis after bone marrow transplant. Bone Marrow Transplant 1997; 19:293-294.
53. Simon MR, Houser WL, Smith KA, Long PM. Esophageal candidiasis as a complication of inhaled corticosteroids. Ann Allergy Asthma Immunol 1997; 79:333-338.
54. Kikendall JW, Johnson LF. Pill-induced esophageal injury. In: Castell DO, ed. The Esophagus. Boston: Little, Brown, 1995.
55. Boyce HW. Drug induced esophageal damage: diseases of medical progress. Gastrointest Endosc 1998; 47:547-550.
56. Kikendall JW. Pill-induced esophageal injury. Gastroenterol Clin North Am 1991; 20:835-846.
57. Yamaoka K, Takenawa H, Tajiri K, Yamane M, Kadowaki K, Marumo F, Sato C. A case of esophageal perforation due to a pill-induced ulcer successfully treated with conservative measures. Am J Gastroenterol 1996; 91:1044-1045.
58. Simko V, Joseph D, Michael S. Increased risk in esophageal obstruction with slowrelease medications. J Assoc Acad Minor Phys 1997; 8:38-42.
59. de Groen PC, Lubbe DF, Hirsch LJ, Daifotis A, Stephenson W, Freedholm D, Pryor-Tillotson S, Seleznick MJ, Pinkas H, Wang KK. Esophagitis associated with the use of alendronate. N Engl J Med 1996; 335:1016-1021.
60. Ribeiro A, DeVault KR, Wolfe JE III, Start ME. Alendronate associated esophagitis: endoscopic and pathologic features. Gastrointest Endosc 1998; 47:525-528.
61. Sugawa C, Takekuma Y, Lucas CE, Amamoto H. Bleeding esophageal ulcers caused by NSAID's. Surg Endosc 1997; 11:143-146.
62. Katz PO, Codario R, Castell DO. Approach to the patient with unexplained chest pain. Comprehens Ther 1997; 23:249-253.
63. Braunwald E. Examination of the patient. In: Braunwald E, ed. Heart Disease, 5th ed. Philadelphia: WB Saunders, 1997:1-14.
64. Epstein SE, Talbot TL. Dynamic coronary tone in precipitation, exacerbation and relief of angina pectoris. Am J Cardiol 1981; 48:797-803.
65. Prinzmetal M, Kennamer R, Merliss R, et al. A variant form of angina pectoris. Am J Med 1959; 27:375.
66. Mehta AJ, de Caestecker JS, Camm AJ, Northfield TC. Gastro-oesophageal reflux in patients with coronary disease: how common is it and does it matter? Eur J Gastroenterol Hepatol 1996; 8:973-978.
67. Singh S, Richter JE, Hewson EG, Sinclair JW, Hackshaw BT. The contribution of gastroesophageal reflux to chest pain in patients with coronary artery disease. Ann Intern Med 1992; 117:824-830.
68. Voskuil JH, Cramer MJ, Breumelhof R, Timmer R, Smout AJ. Prevalence of esophageal disorders in patients with chest pain newly referred to a cardiologist. Chest 1996; 109:1210-1214.
69. Goyal RK. Changing focus on unexplained esophageal chest pain. Ann Intern Med 1996; 124:1008-1011.
70. Pasricha PJ. Noncardiac chest pain: from nutcracker to nociceptors. Gastroenterology 1997; 112:309-310.
71. Rao SS, Gregersen H, Hayek B, Summers RW, Christensen J. Unexplained chest pain: the hypersensitive, hyperactive, and poorly compliant esophagus. Ann Intern Med 1996; 124:950-958.
72. Mehta AJ, DeCaestecker JS, Camm AJ, Northfield TC. Sensitization to painful distention and abnormal sensory perception in the esophagus. Gastroenterology 1995; 108:311-319.
73. Achem SR, Kolts BE, Richter JE, Castell DO. Treatment of acid related chest pain: a double-blind, placebo controlled trial of omperazole vs. placebo. Gastroenterology 1993; 104:A29.
74. Ho KY, Kang JK, Yeo B, Ng WL. Non-cardiac, non-oesophageal chest pain: the relevance of psychological factors. Gut 1998; 43:105-110.
75. Spechler SJ. Barrett's esophagus. Curr Opinion Gastroenterol 1988; 4:535-541.
76. Spechler SJ, Schimmel EM. Gastrointestinal tract bleeding of unknown origin. Arch Intern Med 1982; 142:236-240.
77. Spechler SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992; 51:24-29.
78. Silverstein FE, Gilbert DA, Tedesco FJ, Buenger NK, Persing J. The national ASGE survey on upper gastrointestinal bleeding. II. Clinical and prognostic factors. Gastrointest Endosc 1981; 27:80-93.
79. Murphy PP, Ballinger PJ, Massey BT, Shaker R, Hogan WJ. Discrete ulcers in Barrett's esophagus: relationship to acute gastrointestinal bleeding. Endoscopy 1998; 30:367-370.
80. Kelly JP, Kaufman DW, Jurgelon JM, Sheehan J, Koff RS, Shapiro S. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated and buffered product. Lancet 1996; 348:1413-1416.
81. Duchini A, Sessoms SL. Gastrointestinal hemorrhage in patients with systemic sclerosis and CREST syndrome. Am J Gastroenterol 1998; 93:1453-1456.
82. Weston AP. Hiatal hernia with Cameron ulcers and erosions. Gastrointest Endosc Clin North Am 1996; 6:671-679.
83. Maziak DE, Todd TR, Pearson FG. Massive hiatus hernia: evaluation and surgical management. J Thorac Cardiovasc Surg 1998; 115:53-60.
84. Lundell L, Ruth M, Sandberg N, Bove-Nielsen M. Does massive obesity promote abnormal gastroesophageal reflux? Dig Dis Sci 1995; 40:1632-1635.
85. Castell DO. Obesity and gastro-oesophageal reflux: is there a relationship? Eur J Gastroenterol Hepatol 1996; 8:625-626.
86. Savary M, Ollyo J-B. L'oesophagite par reflux et ses complications: ulcere, stenose, endobrachy-oesophage. Encycl Med Chir (Paris, France) ORL 1986; 20822A10: 16.
87. Kahrilas PJ. Gastroesophageal reflux disease. JAMA 1996; 276:983-988.
88. A Gallup Survey on Heartburn Across America. Princeton, NJ: Gallop Organization, 1988.
89. Ollyo J-B, Monnier P, Fontolliet C, Savary M. The natural history, prevalence and incidence of reflux oesophagitis. Gullet 1993; 3(suppl):3-10.
90. Ollyo J-B, Ferrarini F, Morselli Labate AM, Barbara L. Prevalence of esophagitis in patients undergoing routine upper endoscopy: a multicenter survey in Italy. In: DeMeester TR, Skinner DB, eds. Esophageal Disorders: Pathophysiology and Therapy. New York: Raven Press, 1985:213-219.
91. Collen MJ, Abdulian JB, Chen YK. Gastroesophageal reflux disease that requires aggressive therapy. Am J Gastroenterol 1995; 90:1053-1057.
92. Howard PJ, Heading RC. Epidemiology of gastro-esophageal reflux disease. World J Surg 1992; 16:288-293.
93. Rex JC, Anderson HA, Bartholomew LG, Cain JC. Esophageal hiatial hernia-a 10 year study of medically treated cases. JAMA 1961; 178:117-120.
94. Wienbeck M, Barnert J. Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol 1989; 156(suppl):7-13.
95. Spechler SJ, Sperber H, Doos WG, Schimmel EM. The prevalence of Barrett's esophagus in patients with chronic peptic esophageal strictures. Dig Dis Sci 1983; 28:769.
96. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986; 315:362-371.
97. Winters C, Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker JF III, Johnson DA, Spurling TJ, Cruess DF, Cotelingam JD, Gurney MS, Cattau EL. Barrett's esophagus: a prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987; 92:118-124.
98. Corder AO, Jones RH, Sadler GH, Daniels P, Johnson CD. Heartburn, oesophagitis and Barrett's esophagus in self-medicated patients in general practice. Br J Clin Pract 1996; 50:245-248.
99. Johnston BT, Gunning J, Lewis SA. Health care seeking by heartburn sufferers is associated with psychosocial factors. Am J Gastroenterol 1996; 91:2500-2504.
100. Tew S, Jamieson GG, Pilowsky I, Myers J. The illness behavior of patients with gastroesophageal reflux disease with and without endoscopic esophagitis. Dis Esoph 1997; 10:9-15.
101. Pace F. Santalucia F, Bianchi Porro G. Natural history of gastro-oesophageal reflux disease without esophagitis. Gut 1991; 32:845-848.
102. Isolauri J, Loustarinen M, Isolauri E, Reinikainen P, Viljakka M, Keyrilainen O. Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients. Am J Gastroenterol 1997; 92:37-41.
103. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnarlined (Barrett's) esophagus. Gastroenterology 1990; 99:918-922.
104. Klinkenberg-Knol EC, Festen HP, Jansen JB, et al. Long-term treatment with omperazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med 1994; 121:161-169.
105. Ollyo J-B, Lang F, Fontolliet CH, Monnier PH. Savary-Miller's new endoscopic grading of reflux-oesophagitis: a simple, reproducible, logical, complete and useful classification. Gastroenterology 1990; 98:100A.
106. Silverstein FE, Tytgat GNJ. Esophagus I and II. In: Silverstein FE, Tytgat GNJ, eds. Gastrointestinal Endoscopy, 3rd ed. Philadelphia: Mosby-Wolfe, 1997:29-89.
107. Eisenberg RL. Esophageal ulceration. In: Eisenberg RL, ed. Gastrointestinal Radiology: A Pattern Approach, 3rd ed. Philadelphia: Lippincott-Raven, 1996:45-69.
108. Vincent ME, Robbins AH, Spechler SJ, Schwartz R, Doos WG, Schimmel EM. The reticular pattern as a radiographic sign of Barrett esophagus: an assessment. Radiology 1984; 153:333-335.
109. Wolf BS, Brahms SA, Khilnani MT. The incidence of hiatus hernia in routine barium meal examination. J Mt Sinai Hosp 1959; 26:598-600.
110. Palmer ED. The hiatus hernia-esophagitis-esophageal stricture complex. Twentyyear prospective study. Am J Med 1968; 44:566-579.
111. El-Serag HB, Sonnenberg A. Associations between different forms of gastrooesophageal reflux disease. Gut 1997; 41:594-599.
112. El-Serag HB, Sonnenberg A. Association of esophageal strictures with diseases treated with nonsteroidal anti-inflammatory drugs. Am J Gastroenterol 1997; 92: 52-56.
113. Ismail-Beigi, Horton PF, Pope CE 2nd. Histologic consequences of gastroesophageal reflux in man. Gastroenterology 1970; 58:163-174.
114. Ismail-Beigi, Pope CE 2nd. Distribution of histological changes of gastroesophageal reflux in the distal esophagus of man. Gastroenterology 1974; 66:1109-1113.